2015
DOI: 10.4081/or.2015.5920
|View full text |Cite
|
Sign up to set email alerts
|

Quality of life, physical and mental status and contentment of patients with localized soft tissue or bone sarcoma: a questionnaire analysis

Abstract: Extremity soft tissue and bone sarcomas represent a rare group of bone and connective tissue cancers. In literature, there is little information about psycho-emotional status and impact on quality of life after the diagnosis and treatment of this kind of tumors. The aim of this survey was to define the profile of the patients at risk and their need for psychooncological care. Our self-created questionnaire consists of 71 items related to the individual emotional, mental and physical situation after the diagnos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
51
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(55 citation statements)
references
References 15 publications
(18 reference statements)
0
51
0
Order By: Relevance
“…22 Existing research into the HRQoL of patients with sarcoma has primarily focused on survivors of localised extremity STS, or specific subgroups of patients with advanced STS. [23][24][25][26] For example, the SABINE study evaluated HRQoL among patients with metastatic STS or bone sarcoma who had attained a favourable response to chemotherapy. 27 The PALETTE trial of pazopanib versus placebo, as second-line treatment (or greater) for patients with advanced STS, evaluated HRQoL as an exploratory endpoint.…”
Section: Ethics and Dissemination Heath Research Authority And Researmentioning
confidence: 99%
“…22 Existing research into the HRQoL of patients with sarcoma has primarily focused on survivors of localised extremity STS, or specific subgroups of patients with advanced STS. [23][24][25][26] For example, the SABINE study evaluated HRQoL among patients with metastatic STS or bone sarcoma who had attained a favourable response to chemotherapy. 27 The PALETTE trial of pazopanib versus placebo, as second-line treatment (or greater) for patients with advanced STS, evaluated HRQoL as an exploratory endpoint.…”
Section: Ethics and Dissemination Heath Research Authority And Researmentioning
confidence: 99%
“… 75 76 During treatment, fatigue, nausea and vomiting, appetite loss, drowsiness, shortness of breath and poor general well-being increased and physical functioning deteriorated, but pain scores improved. 75 76 When treatment was completed, almost 50% of patients considered their physical condition as stable and excellent 77 ; 17%–29% of patients reported severe fatigue. 78 …”
Section: Resultsmentioning
confidence: 99%
“…79 80 Undesirable effects of therapy were considered as the main stress factor. 77 After curative treatment, only one-third of patients regarded themselves to be completely emotionally stable and just over 50% had great confidence in the future. 77 Lower social functioning scores and more financial problems than the normative population were reported by patients with sarcoma at diagnosis.…”
Section: Localised Sarcomamentioning
confidence: 99%
See 2 more Smart Citations